Thyssenkrupp Nucera cites regulatory uncertainty as hurdle for European hydrogen investment
Thyssenkrupp Nucera says regulatory uncertainty is impeding investment in Europe's hydrogen market.
Related stories
CEPCO Seeks Approval for Buyback of Up to 10% of Shares
CEPCO will seek shareholder approval for the buyback.
M impact | EQUITY | Oct 30, 2026, 02:05 AM UTC
Vale Q3 Profit Tumbles as Iron Ore Output Misses Forecasts
Vale’s adjusted EBITDA was in line.
M impact | EQUITY | Oct 30, 2026, 02:04 AM UTC
Taiwan's Taiex Falls 3.0% to 44983.64
M impact | EQUITY | Oct 30, 2026, 02:03 AM UTC
SAIC Motor Shares Fall 5.9% as Q3 Profit Plunges
SAIC Motor shares fell 5.9% in early trading to a two-month low. The automaker reported third-quarter net profit on Thursday.
M impact | EQUITY | Oct 30, 2026, 02:03 AM UTC
Boston Scientific Reports Q3 Sales of $5.138 Billion, Lowers 2026 EPS Guidance
Boston Scientific reported Q3 2026 sales of $5.138 billion, up 1.5% year over year, and adjusted EPS of $0.73. It lowered full-year adjusted EPS guidance to $3.16–$3.18, citing Chi
M impact | EQUITY | Oct 30, 2026, 02:02 AM UTC
Indonesia's Benchmark Stock Index Falls 0.9% to 5,054.729
M impact | EQUITY | Oct 30, 2026, 02:01 AM UTC